Background Recognition of out-of-hospital-cardiac arrests (OHCAs) at emergency medical communication centres is based on questions of OHCA symptoms, resulting in 50–80% accuracy rates. However, OHCAs might be recognized more promptly using ‘rhythm-based’ recognition, whereby a victim’s cardiac rhythm is recorded with mobile phone technology that analyses and transmits recordings to emergency medical communication centres for further interpretation. Objective To examine whether the quality of normal cardiac rhythm and the rhythm with the best prognosis in OHCA, ventricular fibrillation (VF), is sufficient for ‘rhythm-based’ OHCA recognition when recorded within a mobile phone-sized device. Patients and methods mid-sternum within an area the size of a mobile phone and analysed by automated external defibrillator (AED) software and two cardiologists. The rhythms were categorized as shockable or nonshockable. The cardiologists assessed the quality of the recordings. Results The AED software correctly analysed all normal rhythms and 15 of 22 VF rhythms. The VF duration was too short for automatic detection in seven cases. The cardiologists analysed all the normal rhythms and VF sequences correctly and graded them as high quality. Conclusion The recordings of normal ECG rhythm and VF within an area the size of a mobile phone are of sufficient quality and could be used in ‘rhythm-based’ OHCA recognition. The VF period was too short for an accurate analysis by the AED software in some cases. Correspondence to Sakari Syväoja, MD, Department of Anaesthesia and Intensive Care, North Karelia Central Hospital, Tikkamäentie 16, FIN-80210 Joensuu, Finland Tel: +358 50 387 7747; e-mail: sakari.syvaoja@siunsote.fi Received December 18, 2016 Accepted April 27, 2017 Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.
from Emergency Medicine via xlomafota13 on Inoreader https://ift.tt/2xvY0qM
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Ravulizumab (ravulizumab-cwvz; ULTOMIRIS™), a humanized monoclonal antibody, is a complement C5 inhibitor developed by Alexion Ph...
-
http://bit.ly/2TO0eLw
-
Training in teamwork behaviour improves technical resuscitation performance. However, its effect on patient outcome is less clear, partly be...
-
Abstract Objective Long-acting synthetic somatostatin analogues (SSA) are an essential part of the treatment of neuroendocrine neoplasms...
-
Medicine by Alexandros G. Sfakianakis BioMed Research International BioMed Research InternationalTanshinone IIA Alleviates CCL2-Induced Le...
-
Abstract Chronic venous disease (CVD) is both prevalent and unavoidable in many people as a result of persistent or unalterable risk facto...
-
Abstract Chronic low-grade inflammation is now widely accepted as one of the most important contributors to metabolic disorders. Glycoprot...
-
Medicine by Alexandros G. Sfakianakis Atmosphere, Vol. 11, Pages 876: The Distribution... Behavioural Brain ResearchAcute serotonin 2A r...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου